Pan B-Cell Surface Marker Bispecific Antibody: Domain-Specific ADA and Cell-Based Neutralizing Antibody Assay Development for Clinical Immunogenicity Assessment
Develop, optimize, and qualify assay for multiple biomarkers to assess inflammatory change for the Sponsor. in different biological matrices utilizing...